1-3 of 3
David L. Becton
Close
Sort by
Journal Articles

Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia

Clinical Trials & Observations
Yubin Ge, Alan A. Dombkowski, Katherine M. LaFiura, Dana Tatman, Ravikiran S. Yedidi, Mark L. Stout, Steven A. Buck, Gita Massey, David L. Becton, Howard J. Weinstein, Yaddanapudi Ravindranath, Larry H. Matherly, Jeffrey W. Taub
Journal: Blood
Blood (2006) 107 (4): 1570–1581.
https://doi.org/10.1182/blood-2005-06-2219
Published: 2006
Journal Articles

Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes

Clinical Trials & Observations
Norman J. Lacayo, Soheil Meshinchi, Paivi Kinnunen, Ron Yu, Yan Wang, Christianna M. Stuber, Lorrie Douglas, Romina Wahab, David L. Becton, Howard Weinstein, Myron N. Chang, Cheryl L. Willman, Jerald P. Radich, Robert Tibshirani, Yaddanapudi Ravindranath, Branimir I. Sikic, Gary V. Dahl
Journal: Blood
Blood (2004) 104 (9): 2646–2654.
https://doi.org/10.1182/blood-2003-12-4449
Published: 2004
Journal Articles

Expression of Chromosome 21-Localized Genes in Acute Myeloid Leukemia: Differences Between Down Syndrome and Non-Down Syndrome Blast Cells and Relationship to In Vitro Sensitivity to Cytosine Arabinoside and Daunorubicin

Jeffrey W. Taub, Xi Huang, Larry H. Matherly, Mark L. Stout, Steven A. Buck, Gita V. Massey, David L. Becton, Myron N. Chang, Howard J. Weinstein, Yaddanapudi Ravindranath
Journal: Blood
Blood (1999) 94 (4): 1393–1400.
https://doi.org/10.1182/blood.V94.4.1393
Published: 1999